IP Library Granted Patent US 8,580,317
Granted Patent B2
US 8,580,317 · App. 11/816,670 · Granted Nov 12, 2013

Compositions and methods for treating acne

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,317
App. No.
11/816,670
Granted
Nov 12, 2013
Kind
B2
Abstract

This invention provides anti-acne kits that are useful for treating acne, especially severe cases of acne. The anti-acne kits include a vasoconstrictor and an anti-acne agent, and optionally one or more of a a skin lightening therapeutic, a sealing layer, a skin cleanser, an astringent, a skin penetration enhancer, a sunscreen, and nutritional supplements that promote healing of acne lesions. This invention also provides methods for treating acne using a vasoconstrictor in conjunction with an anti-acne agent.

Claims (11)

1. A method of treating acne, said method comprising:

applying a vasoconstrictor in a vasoconstricting amount to an acne lesion to achieve a vasoconstrictive effect; and

subsequently applying an anti-acne agent to said acne lesion wherein the anti-acne agent is administered during the vasoconstrictive elect of said vasoconstrictor.

2. The method according to claim 1 , wherein said anti-acne agent is selected from the group consisting of benzoyl peroxide and salicylic acid.

3. The method according to claim 1 , wherein the anti-acne agent is applied from 15 seconds to 30 minutes after the application of the vasoconstrictor.

4. The method according to claim 1 , wherein the anti-acne agent is applied from 45 seconds to 15 minutes after the application of the vasoconstrictor.

5. The method according to claim 1 , wherein the anti-acne agent is applied from one minute to five minutes after the application of the vasoconstrictor.

6. The method according to claim 1 , further comprising the step of applying, after application of the anti-acne agent, one or more components selected from the group consisting of a skin lightening therapeutic, a skin cleanser, an astringent, a sun screen and a sealing layer.

7. The method according to claim 6 , wherein said vasoconstrictor is selected from the group consisting of tetrahydrozoline HCI 0.5%, naphazoline HCl 0.03%, oxymetazoline HCl 0.025%, guava extract, ellagic acid, caffeine, cypress oil, witch hazel, peppermint extract, chamomile oil, and bugleweed.

8. The method according to claim 6 , wherein said skin-lightening therapeutic is selected from the group consisting of albatin, arbutin, bearberry extract, mulberry extract, licorice extract, skull cap, azelaic, ascorbyl glucosamine, magnesium ascorbyl phosphate, ascorbic acid, coltsfoot extract, gallic acid, nutmeg, ramulus mori extract and kojic acid.

9. The method according to claim 6 , wherein said sealing layer comprises mica.

Assignments (8)
SECURITY INTEREST Recorded Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →
SECURITY INTEREST Recorded Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
SECURITY INTEREST Recorded Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2025
From: ATHYRIUM BUFFALO LP
To: REVANCE THERAPEUTICS, INC
Reel/Frame 070153/0630 →
SECURITY INTEREST Recorded Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 24432/321, 24432/284, 24432/317, 22432/187, AND 22756/549 Recorded Oct 4, 2011
From: LEADER VENTURES, LLC
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 027015/0658 →
SECURITY AGREEMENT Recorded May 29, 2009
From: REVANCE THERAPEUTICS, INC.
To: LEADER VENTURES, LLC
Reel/Frame 022756/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2008
From: WAUGH, JACOB M.; LEE, JAE HOON
To: REVANCE THERAPEUTICS, INC
Reel/Frame 021662/0606 →